Music as a sleep aid in fibromyalgia

被引:16
|
作者
Picard, Larry M. [1 ,2 ]
Bartel, Lee R. [1 ]
Gordon, Allan S. [1 ,2 ]
Cepo, Davor [1 ]
Wu, Qi [2 ]
Pink, Leah R. [2 ]
机构
[1] Univ Toronto, Toronto, ON M5S 1A1, Canada
[2] Mt Sinai Hosp, Wasser Pain Management Ctr, Toronto, ON M5G 1X5, Canada
关键词
Delta embedded music; Fibromyalgia; Sleep disorders; PHASE-III TRIAL; MAJOR DEPRESSIVE DISORDER; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; DOUBLE-BLIND; SODIUM OXYBATE; CHRONIC PAIN; IMPACT QUESTIONNAIRE; JAPANESE PATIENTS; CLINICAL-TRIAL;
D O I
10.1155/2014/272108
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Interventions to improve sleep in fibromyalgia may generalize to improvements in multiple symptom domains. Delta-embedded music, pulsating regularly within the 0.25 Hz to 4 Hz frequency band of brain wave activity, has the potential to induce sleep. Objectives: To assess the effects of a delta-embedded music program over four weeks for sleep induction in patients with fibromyalgia. Methods: The present unblinded, investigator-led pilot study used a within-subject design. Analysis was based on 20 individuals with fibromyalgia who completed the study, of the 24 recruited into the study. The primary outcome variables were the change from baseline in Fibromyalgia Impact Questionnaire (FIQ) and Jenkins Sleep Scale scores. A patient global impression of change was measured on a seven-point Likert scale. Secondary outcome measures, comprised of items 5, 6 and 7 of the FIQ, were used as indicators of pain, tiredness and being tired on awakening. Results: The FIQ median score of 76.4 (95% CI 61.3 to 82.1) at baseline improved to 60.3 (95% CI 53.1 to 72.0; P=0.004). The Jenkins Sleep Scale median value of 17.5 (95% CI 15.5 to 18.5) at baseline fell to 12.5 (95% CI 8.5 to 14.5; P=0.001) at study completion. The outcomes of the patient global impression of change ratings were mostly positive (P=0.001). Being tired on awakening declined significantly from a median of 9.0 (95% CI 8.0 to 10.0) to 8.0 (95% CI 5.5 to 9.0; P=0.021). However, there was no significant improvement in pain level (baseline median 7.5 [95% CI 7.0 to 8.5] versus study completion median 7.0 [95% CI 6.5 to 8.0]; P=0.335) or tiredness (baseline median 9.0 [95% CI 8.0 to 9.5] versus study completion median 8.0 [95% CI 6.0 to 8.5]; P=0.061). There were no serious adverse events. Conclusions: Delta-embedded music is a potential alternative therapy for fibromyalgia.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 50 条
  • [21] ZOPICLONE IN THE TREATMENT OF SLEEP ABNORMALITIES IN FIBROMYALGIA
    DREWES, AM
    ANDREASEN, A
    JENNUM, P
    NIELSEN, KD
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (04) : 288 - 293
  • [22] Fibromyalgia Syndrome Treatment from a Multidimensional Perspective
    Spaeth, Michael
    JOURNAL OF MUSCULOSKELETAL PAIN, 2010, 18 (04): : 373 - 379
  • [23] Association Between Sexual Dysfunction, Sleep Impairment and Depression in Women with Fibromyalgia
    Dursun, Murat
    Besiroglu, Huseyin
    Tellioglu, Evrim
    Saglam, Yavuz
    Ortac, Mazhar
    SEXUALITY AND DISABILITY, 2020, 38 (02) : 261 - 269
  • [24] Impact of fibromyalgia severity on patients mood, sleep quality, and quality of life
    Singh, Ruchi
    Rai, Nirendra Kumar
    Pathak, Akash
    Rai, Jyotsana
    Pakhare, Abhijit
    Kashyap, Priyanka Vikas
    Rozatkar, Abhijit R.
    Mishra, Shweta
    Mudda, Sofia
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2024, 15 (02) : 320 - 326
  • [25] Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary
    Leah Kleinman
    Sally Mannix
    Lesley M Arnold
    Claire Burbridge
    Kellee Howard
    Kelly McQuarrie
    Verne Pitman
    Malca Resnick
    Tom Roth
    Tara Symonds
    Health and Quality of Life Outcomes, 12
  • [26] Pharmacotherapy of fibromyalgia
    Mease, Philip J.
    Dundon, Kelly
    Sarzi-Puttini, Piercarlo
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (02): : 285 - 297
  • [27] Pharmacotherapy for fibromyalgia
    Smith, Howard S.
    Bracken, Donna
    Smith, Joshua M.
    FRONTIERS IN PHARMACOLOGY, 2011, 2
  • [28] Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire
    Bennett, Robert M.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Zlateva, Gergana
    Sadosky, Alesia B.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1304 - 1311
  • [29] Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy
    Hsu, Eric S.
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (06) : 487 - 509
  • [30] Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology
    Kia, Sanam
    Choy, Ernet
    BIOMEDICINES, 2017, 5 (02)